ペニシリンの世界市場 2024-2028

ペニシリン市場は2023-2028年に28億2,000万米ドル、予測期間中のCAGRは5.4％で成長すると予測されます。

当レポートでは、ペニシリン市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、感染症の有病率の上昇、様々な疾患とその治療に対する意識の高まり、ペニシリンの品質を促進する特別な規制指定によって牽引されています。

本調査では、ペニシリンベンダー間の戦略的提携やM&Aが、今後数年間のペニシリン市場成長を牽引する主要因の1つであると分析しています。また、抗生物質研究への資金提供の増加や輸血による感染拡大のリスクの高まりも、市場の大きな需要につながると思われます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• ペニシリンの世界市場 2018-2022
• ソースセグメント分析 2018-2022
• タイプセグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：ソース別

• 市場セグメント
• 比較：ソース別
• 半合成：市場規模と予測 2023-2028
• 天然：市場規模と予測 2023-2028
• 市場機会：ソース別

第7章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• 経口：市場規模と予測 2023-2028
• 非経口：市場規模と予測 2023-2028
• 市場機会：タイプ別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Abbott Laboratories
• AdvaCare Pharma
• Aenova Holding GmbH
• Canvax Biotech SL
• Cipla Ltd.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Glenmark Pharmaceuticals Ltd.
• Lupin Ltd.
• Merck KGaA
• Novartis AG
• Pfizer Inc.
• Recipharm AB
• Sanofi SA
• Viatris Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Source
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global penicillin market 2018 - 2022 ($ billion)
• Exhibits19: Historic Market Size - Source Segment 2018 - 2022 ($ billion)
• Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Source - Market share 2023-2028 (%)
• Exhibits31: Data Table on Source - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Source
• Exhibits33: Data Table on Comparison by Source
• Exhibits34: Chart on Semisynthetic - Market size and forecast 2023-2028 ($ billion)
• Exhibits35: Data Table on Semisynthetic - Market size and forecast 2023-2028 ($ billion)
• Exhibits36: Chart on Semisynthetic - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Semisynthetic - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Natural - Market size and forecast 2023-2028 ($ billion)
• Exhibits39: Data Table on Natural - Market size and forecast 2023-2028 ($ billion)
• Exhibits40: Chart on Natural - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Natural - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Source ($ billion)
• Exhibits43: Data Table on Market opportunity by Source ($ billion)
• Exhibits44: Chart on Type - Market share 2023-2028 (%)
• Exhibits45: Data Table on Type - Market share 2023-2028 (%)
• Exhibits46: Chart on Comparison by Type
• Exhibits47: Data Table on Comparison by Type
• Exhibits48: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
• Exhibits49: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
• Exhibits50: Chart on Oral - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on Oral - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Parenteral - Market size and forecast 2023-2028 ($ billion)
• Exhibits53: Data Table on Parenteral - Market size and forecast 2023-2028 ($ billion)
• Exhibits54: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
• Exhibits56: Market opportunity by Type ($ billion)
• Exhibits57: Data Table on Market opportunity by Type ($ billion)
• Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits61: Chart on Geographic comparison
• Exhibits62: Data Table on Geographic comparison
• Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits84: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits85: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibits96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibits97: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits99: Market opportunity By Geographical Landscape ($ billion)
• Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits101: Impact of drivers and challenges in 2023 and 2028
• Exhibits102: Overview on Criticality of inputs and Factors of differentiation
• Exhibits103: Overview on factors of disruption
• Exhibits104: Impact of key risks on business
• Exhibits105: Vendors covered
• Exhibits106: Matrix on vendor position and classification
• Exhibits107: Abbott Laboratories - Overview
• Exhibits108: Abbott Laboratories - Business segments
• Exhibits109: Abbott Laboratories - Key news
• Exhibits110: Abbott Laboratories - Key offerings
• Exhibits111: Abbott Laboratories - Segment focus
• Exhibits112: AdvaCare Pharma - Overview
• Exhibits113: AdvaCare Pharma - Product / Service
• Exhibits114: AdvaCare Pharma - Key offerings
• Exhibits115: Aenova Holding GmbH - Overview
• Exhibits116: Aenova Holding GmbH - Product / Service
• Exhibits117: Aenova Holding GmbH - Key offerings
• Exhibits118: Canvax Biotech SL - Overview
• Exhibits119: Canvax Biotech SL - Product / Service
• Exhibits120: Canvax Biotech SL - Key offerings
• Exhibits121: Cipla Ltd. - Overview
• Exhibits122: Cipla Ltd. - Business segments
• Exhibits123: Cipla Ltd. - Key news
• Exhibits124: Cipla Ltd. - Key offerings
• Exhibits125: Cipla Ltd. - Segment focus
• Exhibits126: F. Hoffmann La Roche Ltd. - Overview
• Exhibits127: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits128: F. Hoffmann La Roche Ltd. - Key news
• Exhibits129: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits130: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits131: GlaxoSmithKline Plc - Overview
• Exhibits132: GlaxoSmithKline Plc - Business segments
• Exhibits133: GlaxoSmithKline Plc - Key news
• Exhibits134: GlaxoSmithKline Plc - Key offerings
• Exhibits135: GlaxoSmithKline Plc - Segment focus
• Exhibits136: Glenmark Pharmaceuticals Ltd. - Overview
• Exhibits137: Glenmark Pharmaceuticals Ltd. - Product / Service
• Exhibits138: Glenmark Pharmaceuticals Ltd. - Key offerings
• Exhibits139: Lupin Ltd. - Overview
• Exhibits140: Lupin Ltd. - Product / Service
• Exhibits141: Lupin Ltd. - Key news
• Exhibits142: Lupin Ltd. - Key offerings
• Exhibits143: Merck KGaA - Overview
• Exhibits144: Merck KGaA - Business segments
• Exhibits145: Merck KGaA - Key news
• Exhibits146: Merck KGaA - Key offerings
• Exhibits147: Merck KGaA - Segment focus
• Exhibits148: Novartis AG - Overview
• Exhibits149: Novartis AG - Business segments
• Exhibits150: Novartis AG - Key offerings
• Exhibits151: Novartis AG - Segment focus
• Exhibits152: Pfizer Inc. - Overview
• Exhibits153: Pfizer Inc. - Product / Service
• Exhibits154: Pfizer Inc. - Key news
• Exhibits155: Pfizer Inc. - Key offerings
• Exhibits156: Recipharm AB - Overview
• Exhibits157: Recipharm AB - Business segments
• Exhibits158: Recipharm AB - Key offerings
• Exhibits159: Recipharm AB - Segment focus
• Exhibits160: Sanofi SA - Overview
• Exhibits161: Sanofi SA - Business segments
• Exhibits162: Sanofi SA - Key news
• Exhibits163: Sanofi SA - Key offerings
• Exhibits164: Sanofi SA - Segment focus
• Exhibits165: Viatris Inc. - Overview
• Exhibits166: Viatris Inc. - Business segments
• Exhibits167: Viatris Inc. - Key news
• Exhibits168: Viatris Inc. - Key offerings
• Exhibits169: Viatris Inc. - Segment focus
• Exhibits170: Inclusions checklist
• Exhibits171: Exclusions checklist
• Exhibits172: Currency conversion rates for US$
• Exhibits173: Research methodology
• Exhibits174: Validation techniques employed for market sizing
• Exhibits175: Information sources
• Exhibits176: List of abbreviations

The penicillin market is forecasted to grow by USD 2.82 bn during 2023-2028, accelerating at a CAGR of 5.4% during the forecast period. The report on the penicillin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of infectious diseases, growing awareness of various diseases and their treatment, and special regulatory designations driving the quality of penicillin.

Technavio's penicillin market is segmented as below:

By Source

• Semisynthetic
• Natural

By Type

• Oral
• Parenteral

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the strategic alliances and M and A among penicillin vendors as one of the prime reasons driving the penicillin market growth during the next few years. Also, increased funding for antibiotic research and the growing risk of spreading infections via blood transfusions will lead to sizable demand in the market.

The report on the penicillin market covers the following areas:

• Penicillin market sizing
• Penicillin market forecast
• Penicillin market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading penicillin market vendors that include Abbott Laboratories, AdvaCare Pharma, Aenova Holding GmbH, Astellas Pharma Inc., Canvax Biotech SL, Cipla Ltd., F. Hoffmann La Roche Ltd., Fermenta Biotech Ltd., Focus Technology Co. Ltd., FUJIFILM Corp., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Lupin Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Recipharm AB, Sanofi SA, Viatris Inc., and Wellona Pharma. Also, the penicillin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global penicillin market 2018 - 2022
• 4.2 Source Segment Analysis 2018 - 2022
• 4.3 Type Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Source

• 6.1 Market segments
• 6.2 Comparison by Source
• 6.3 Semisynthetic - Market size and forecast 2023-2028
• 6.4 Natural - Market size and forecast 2023-2028
• 6.5 Market opportunity by Source

7 Market Segmentation by Type

• 7.1 Market segments
• 7.2 Comparison by Type
• 7.3 Oral - Market size and forecast 2023-2028
• 7.4 Parenteral - Market size and forecast 2023-2028
• 7.5 Market opportunity by Type

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 UK - Market size and forecast 2023-2028
• 9.9 China - Market size and forecast 2023-2028
• 9.10 Germany - Market size and forecast 2023-2028
• 9.11 Canada - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Abbott Laboratories
• 12.4 AdvaCare Pharma
• 12.5 Aenova Holding GmbH
• 12.6 Canvax Biotech SL
• 12.7 Cipla Ltd.
• 12.8 F. Hoffmann La Roche Ltd.
• 12.9 GlaxoSmithKline Plc
• 12.10 Glenmark Pharmaceuticals Ltd.
• 12.11 Lupin Ltd.
• 12.12 Merck KGaA
• 12.13 Novartis AG
• 12.14 Pfizer Inc.
• 12.15 Recipharm AB
• 12.16 Sanofi SA
• 12.17 Viatris Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations